H34.819
Central retinal vein occlusion, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Central retinal vein occlusion (CRVO) is a common eye condition that affects the blood flow in the retina, the light-sensitive tissue at the back of your eye. This disorder occurs when the main vein responsible for draining blood from the retina becomes blocked. The condition, often noted with the ICD-10 code H34.819, can lead to sudden vision loss or blurry vision, particularly affecting one eye. Although it can develop suddenly, understanding the underlying mechanisms and risk factors can aid in early recognition and management.
Causes & Symptoms
Clinical Causes: Blood clots forming within the central retinal vein Atherosclerosis, which is the hardening of arteries, leading to narrowed blood vessels High blood pressure (hypertension) Diabetes mellitus, especially poorly controlled Glaucoma, increased pressure within the eye Blood disorders that increase clotting risk, such as sickle cell anemia or hypercoagulable states Inflammatory conditions affecting blood vessels Age-related changes, typically occurring in individuals over 50
Key Symptoms: Sudden, painless loss of vision in one eye Blurred or distorted vision Seeing floaters or dark spots Sudden decrease in visual acuity In some cases, mild discomfort around the eye
Diagnostic & Treatment
Diagnosis Path: Diagnosis of central retinal vein occlusion primarily involves a comprehensive eye exam. An ophthalmologist will examine the eye, checking the retina and blood vessels. Diagnostic tools include:
Treatment Protocols: While there is no cure for CRVO, various treatments aim to manage symptoms and prevent complications. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is H34.819 a billable ICD-10 code?
Yes, H34.819 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H34.819?
Clinical documentation must specify the nature of Central retinal vein occlusion, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference